公告日期：2025-05-30

Pharmaron Beijing Co., Ltd.

康龙化成（北京）新药技术股份有限公司

2025 H Share Award and Trust Scheme

2025年H股奖励信托计划

Table of Contents 目录

1. Definitions and Interpretation 定义和解释 ...... 1

2. General Introduction and Purpose of the Scheme 本计划概览与目的...... 5

3. Conditions 条件...... 7
4. Duration 期限 ...... 7
5. Administration 管理 ...... 7

6. Selection of Selected Participant 选定参与者的选择...... 10

7. Award Letter regarding Grant of Awards 奖励授予的奖励函 ...... 15

8. Receipt of Treasury H Shares by the Trustee 受托人接受库存H股股票的转让...... 15

9. Granting and Vesting of Award 奖励的授予及归属 ...... 16
10. Changes of Circumstances Pertaining to the Selected Participants and Clawback Mechanism 选定参

与者的情况变化及回拨机制 ...... 20

11. Transferability and Other Rights to Award Shares 授予股票的转让及其他权利 ...... 23

12. Interest in the Assets of the Trust 信托资产权益 ...... 24

13. Restrictive Covenants 限制性条款 ...... 25
14. Takeover, Rights Issue, Open Offer, Scrip Dividend Scheme, etc. 收购、配股、公开发售、股票

分红计划等 ...... 26

Change in control 控制权变更 ...... 26

Open offer and rights issue 公开发行和配股 ...... 26

Bonus warrants 红利认股权证 ...... 26
Scrip dividend 股票股利 ...... 26

Consolidation, sub-division, capitalization issue 合并、分立、资本化发行...... 27

Voluntary winding-up 自动清盘 ...... 28

Compromise or arrangement 和解或偿债安排 ...... 28

15. Scheme Mandate Limit 计划授权上限 ...... 29

16. Returned Shares 退还股票 ...... 31
17. Interpretation 解释...... 31

18. Amendment of the Scheme 方案修订...... 31

19. Cancellation of Awards 取消奖励...... 32

20. Termination 计划终止...... 32
21. Miscellaneous 其他条款 ...... 33

22. Dispute Resolution 争议解决 ...... 36

23. Governing law 适用法律...... 36
24. Translation 翻译 ...... 36

1. Definitions and Interpretation 定义和解释

1.1 In these Scheme Rules, unless the context otherwise requires, each of the following words and
expressions shall have the meaning respectively shown opposite to it:

在本计划中，除非文中另有所指，释义如下：

“Actu……
[点击查看PDF原文]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。